본문 바로가기
KERD
논문KCI 등재

Ombitasvir/paritaprevir/ritonavir+dasabuvir and ribavirin associated drug-induced liver injury and syndrome of inappropriate secretion of anti-diuretic hormone: A case report

John Chen Hsiang|Prem Harichander Thurairajah|Jessica Tan|Rahul Kumar
대한간학회 (The korean Association for the Study of the Liver)|2019.09|Clinical and Molecular Hepatology|제25권 제3호|pp. 326-330

0

조회

0

다운로드

0

인용

0

참고문헌

참고문헌 (15)

  1. Manns MP, "Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C : a randomized trial", Lancet, 358, pp.958~965 (2001)
  2. Feld JJ, "Treatment of HCV with ABT-450", r-ombitasvir and dasabuvir with ribavirin, 2014, pp.370, 1594~1603
  3. Poordad F, "ABT-460", r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis, 2014, pp.370, 1973~1982
  4. "HCV guidance: recommendations for testing, managing, and treating hepatitis C"[URL]
  5. "EASL recommendations on treatment of hepatitis C 2016 Summary"[URL]
  6. "New Zealand data sheet"[URL]
  7. )for chronic hepatitis C : case report of an unexpected life-threatening adverse reaction, "Case Rep Med", 2017, 4895736~ (2017)
  8. "Database of University of Liverpool"[URL]
  9. Naranjo CA, "A method for estimating the probability of adverse drug reactions", Clin Pharmacol Ther, 30, pp.239~245 (1981)
  10. Hedrick KT, "Probable boceprevir-induced hyponatremia in a patient with chronic hepatitis C", Am J Health Syst Pharm, 72, pp.449~452 (2015)
  11. Au JS, "Review article : Drug-induced liver injury--its pathophysiology and evolving diagnostic tools", Aliment Pharmacol Ther, 34, pp.11~20 (2011)
  12. Danan G, "Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries", J Clin Epidemiol, 46, pp.1323~1330 (1993)
  13. Benichou C, "Causality assessment of adverse reactions to drugs--II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge", J Clin Epidemiol, 46, pp.1331~1336 (1993)
  14. Mendes P, "Statin-induced rhabdomyolysis: a comprehensive review of case reports", Physiother Can, 66, pp.124~132 (2014)
  15. Hui CK, "Pharmacokinetics of pitavastatin in subjects with Child-Pugh A and B cirrhosis", Br J Clin Pharmacol, 59, pp.291~297 (2005)

관련 논문AI추천

Drug-drug interactions with direct-acting antivirals — less is moreGrace Lai-Hung Wong대한간학회 · Clinical and Molecular Hepatology2021 · 제27권 제1호Reply to correspondence on “Adverse impact of metabolic dysfunction on fibrosis regression following direct- acting antiviral therapy: A multicenter study for chronic hepatitis C”Chen-Hua Liu, Yu-Ping Chang대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Metabolic dysfunction in patients following DAAinduced viral cure for HCV infection: A non-negligible risk to liver-related health: Editorial on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C”Chen-Hua Liu, Yu-Ping Chang대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Correspondence to editorial on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C”Jae Young Jang, Seung Up Kim, Tom Ryu, Young Chang대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Efficacy and safety of daclatasvir and asunaprevir for hepatitis C virus genotype 1b infection양현, 남희철, 송명준, 이해림대한간학회 · Clinical and Molecular Hepatology2016 · 제22권 제2호Can We Trust Safety of Tenofovir Disoproxil in Patients with Decompensated Cirrhosis?오현우, 준대원거트앤리버 소화기연관학회협의회 · Gut and Liver2017 · 제11권 제6호

이 간행물의 다른 논문 (11건)

Gadoxetic acid-enhanced magnetic resonance imaging: Hepatocellular carcinoma and mimickersMyeong-Jin Kim, Yeun-Yoon Kim, Jin-Young Choi, 박미숙, Khalid Suliman Aljoqimanpp. 223-233Development and surveillance of hepatocellular carcinoma in patients with sustained virologic response after antiviral therapy for chronic hepatitis C송병철, Seong Kyun Napp. 234-244Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update이정민, So Yeon Kim, Tae-Hyung Kim, An Tangpp. 245-263Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?Ibrahim A. Hanouneh, Amit G. Singal, Naim Alkhouripp. 264-269Sarcopenia: Ammonia metabolism and hepatic encephalopathyAnkur Jindal, Rakesh Kumar Jagdishpp. 270-279
원문 보기